REGENXBIO Inc.（RGNX）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 REGENXBIO Inc.（RGNX）报告了 57 笔 Form 4 交易（最近一笔 2026-09-03）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | Chan Mitchell | Chief Financial Officer | 卖出 | 4,902 | $45,687 |
| 2026-09-03 | Malzahn Craig | Chief Technology Officer | 卖出 | 234 | $2,181 |
| 2026-08-27 | Ciongoli Gregory Austin | 董事 | 买入 | 15,432 | $0 |
| 2026-08-27 | Ciongoli Gregory Austin | 董事 | 买入 | 49,196 | $449,706 |
| 2026-08-27 | Ciongoli Gregory Austin | 董事 | 买入 | 53,407 | $499,676 |
| 2026-08-04 | Christmas Patrick J. | Chief Strategy & Legal Officer | 卖出 | 4,699 | $45,533 |
| 2026-08-04 | PAKOLA STEVE | Chief Medical Officer | 卖出 | 7,468 | $72,365 |
| 2026-07-06 | Simpson Curran | Chief Executive Officer | 买入 | 1,453 | $14,792 |
| 2026-07-06 | PAKOLA STEVE | Chief Medical Officer | 买入 | 2,161 | $16,985 |
| 2026-07-06 | Simpson Curran | Chief Executive Officer | 买入 | 951 | $6,653 |
| 2026-07-06 | PAKOLA STEVE | Chief Medical Officer | 卖出 | 2,161 | $29,476 |
| 2026-07-06 | Simpson Curran | Chief Executive Officer | 卖出 | 6,818 | $89,248 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | 买入 | 36,725 | $288,658 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | 卖出 | 36,725 | $472,284 |
| 2026-07-01 | PAKOLA STEVE | Chief Medical Officer | 卖出 | 19,608 | $216,472 |
| 2026-06-02 | Bennett Jean | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | STUMP DAVID C | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | Fox Allan M. | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | KARABELAS ARGERIS N | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | Zachary Jennifer | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | Tasse Daniel | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | MIGAUSKY GEORGE V | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | Glucksmann Alexandra | 董事 | 买入 | 9,807 | $0 |
| 2026-06-02 | Mills Kenneth T. | 董事 | 买入 | 9,807 | $0 |
| 2026-05-13 | PAKOLA STEVE | Chief Medical Officer | 卖出 | 15,309 | $168,705 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03